Authors:
BRENNAN DC
GARLOCK KA
SINGER GG
SCHNITZLER MA
LIPPMANN BJ
BULLER RS
GAUDREAULTKEENER M
LOWELL JA
SHENOY S
HOWARD TK
STORCH GA
Citation: Dc. Brennan et al., PROPHYLACTIC ORAL GANCICLOVIR COMPARED WITH DEFERRED THERAPY FOR CONTROL OF CYTOMEGALOVIRUS IN RENAL-TRANSPLANT RECIPIENTS, Transplantation, 64(12), 1997, pp. 1843-1846
Authors:
BRENNAN DC
BURTON KG
LIPPMANN BJ
BULLER RS
GAUDREAULTKEENER M
LOWELL JA
MILLER SB
SHENOY S
HOWARD TK
STORCH GA
Citation: Dc. Brennan et al., A COST-EFFECTIVE STRATEGY TO MONITOR AND TREAT CMV IN HIGH-RISK RENAL-TRANSPLANT PATENTS, Journal of investigative medicine, 44(3), 1996, pp. 218-218
Authors:
SINGER GG
STORCH GA
BURTON KG
LIPPMANN BJ
BULLER RS
GAUDREAULTKEENER M
LOWELL JA
SHENOY S
HOWARD TK
BRENNAN DC
Citation: Gg. Singer et al., PROPHYLACTIC ORAL GANCICLOVIR PREVENTS CYTOMEGALOVIRUS DISEASE IN HIGH-RISK RENAL-TRANSPLANT RECIPIENTS, Journal of the American Society of Nephrology, 7(9), 1996, pp. 3469-3469
Authors:
LIPPMANN BJ
BRENNAN DC
WONG J
LOWELL JA
SINGER GG
HOWARD TK
Citation: Bj. Lippmann et al., ARE VARICELLA-ZOSTER AND HERPES-SIMPLEX SENTINEL LESIONS FOR CYTOMEGALOVIRUS IN RENAL-TRANSPLANT RECIPIENTS, Lancet, 346(8979), 1995, pp. 914-915
Citation: Bj. Lippmann et al., PHARMACOLOGY OF VOLUME REGULATION FOLLOWING HYPOTONICITY-INDUCED CELLSWELLING IN CLONAL N1E115 NEUROBLASTOMA-CELLS, Brain research, 686(1), 1995, pp. 29-36